Anders Fomsgaard Selected Research

Anders Fomsgaard Research Topics

20	Infections 01/2023 - 06/2007
9	Human Influenza (Influenza) 01/2023 - 01/2011
7	COVID-19 10/2023 - 01/2021
3	Virus Diseases (Viral Diseases) 09/2023 - 09/2009
3	Orthomyxoviridae Infections 01/2019 - 01/2015
2	Tuberculosis (Tuberculoses) 03/2019 - 09/2009
2	Vaccinia 03/2019 - 10/2006
2	Carcinoma (Carcinomatosis) 11/2007 - 06/2007
2	Neoplasms (Cancer) 11/2007 - 06/2007
1	Type I Syndactyly 09/2023
1	Reinfection 01/2023
1	Breakthrough Infections 01/2022
1	Overweight 01/2021
1	Influenza in Birds (Avian Flu) 01/2021
1	Microcephaly 01/2018
1	Encephalitis (Encephalitis, Rasmussen) 04/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2015
1	HIV Infections (HIV Infection) 01/2015
1	Persistent Infection 01/2013
1	Inflammation (Inflammations) 09/2011
1	Disease Progression 06/2011
1	Malaria 09/2009
1	Lymphoma (Lymphomas) 06/2007

20	VaccinesIBA 10/2023 - 10/2006
10	DNA VaccinesIBA 01/2023 - 01/2011
9	EpitopesIBA 09/2023 - 06/2007
7	Proteins (Proteins, Gene)FDA Link 09/2023 - 06/2007
7	AntibodiesIBA 01/2023 - 01/2015
4	Neuraminidase (Sialidase)IBA 01/2021 - 01/2011
4	NucleoproteinsIBA 01/2021 - 01/2011
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2011
3	Immunoglobulin G (IgG)IBA 02/2022 - 01/2018
3	A-Form DNA (A-DNA)IBA 01/2021 - 04/2013
3	Peptides (Polypeptides)IBA 01/2019 - 06/2007
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023 - 01/2022
2	Hemagglutinins (Hemagglutinin)IBA 01/2018 - 12/2016
2	AIDS VaccinesIBA 01/2015 - 09/2009
2	HLA-A*02:01 antigenIBA 11/2007 - 06/2007
1	Messenger RNA (mRNA)IBA 01/2023
1	Immunoglobulin M (IgM)IBA 02/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2022
1	SARS-CoV-2 spike proteinIBA 12/2021
1	Immunoglobulin A (IgA)IBA 09/2021
1	Interleukin-6 (Interleukin 6)IBA 03/2019
1	LigandsIBA 03/2019
1	MVA 85AIBA 03/2019
1	Combined VaccinesIBA 01/2019
1	Tocopherols (Tocopherol)IBA 01/2017
1	EmulsionsIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 04/2016
1	Protein Subunit VaccinesIBA 11/2013
1	Influenza Vaccines (Influenza Vaccine)FDA Link 04/2013
1	Broadly Neutralizing AntibodiesIBA 01/2013
1	Matrix-MIBA 01/2011
1	Complementary DNA (cDNA)IBA 11/2007
1	B-Form DNA (B-DNA)IBA 06/2007
1	AntigensIBA 06/2007

3	Art Therapy 01/2015 - 01/2013
2	Therapeutics 03/2008 - 06/2007
1	Medical Day Care (Partial Hospitalization) 01/2023
1	Patient Isolation 01/2021
1	Intradermal Injections 12/2016
1	Mass Drug Administration 01/2015
1	Highly Active Antiretroviral Therapy (HAART) 06/2011